Beaudry M, Hidalgo M, Launay T, Bello V, Darribère T. Regulation of myogenesis by environmental hypoxia. J Cell Sci. 2016;129(15):2887-96. [IF=4.43]

De Margerie-Mellon C, Dion G, Darlay J, Ridene I, Kambouchner M, Brauner N, Brauner M, Valeyre D, Brillet PY. High-resolution computed tomography to differentiate chronic diffuse infiltrative lung diseases with chronic multifocal consolidation patterns using logical analysis of data. Sarcoidosis Vasc Diffuse Lung Dis. 2016 Dec 23;33(4):355-371. [IF=1.58]

Duchemann B, Triba MN, Guez D, Rzeznik M, Savarin P, Nunes H, Valeyre D, Bernaudin JF, Le Moyec L. Nuclear magnetic resonance spectroscopic analysis of salivary metabolome in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2016 Mar 29;33(1):10-6. [IF=1.58]

Hermand E, Voituron N, Lhuissier FJ, Richalet JP. Reply to Drs. Teppema, Berendsen, and Swenson. J Appl Physiol (1985). 2016;120(12):1492. [IF=3.35]

Hermand E., Lhuissier F.J., Voituron N., Richalet J.P. (2016). Ventilatory oscillations at exercise in hypoxia: A mathematical model. J Theor Biol 411:92-101. [IF=2.11]

Pacheco Y, Calender A, Israël-Biet D, Roy P, Lebecque S, Cottin V, Bouvry D, Nunes H, Sève P, Pérard L, Devouassoux G, Freymond N, Khouatra C, Wallaert B, Lamy R, Elsensohn MH, Bardel C, Valeyre D; GSF group. Familial vs. sporadic sarcoidosis: BTNL2 polymorphisms, clinical presentations, and outcomes in a French cohort.Orphanet J Rare Dis. 2016 Dec 3;11(1):165. [IF=3.51]

Perrin-Terrin AS, Jeton F, Pichon A, Frugière A, Richalet JP, Bodineau L, Voituron N. The c-FOS Protein Immunohistological Detection: A Useful Tool As a Marker of Central Pathways Involved in Specific Physiological Responses In Vivo and Ex Vivo.J Vis Exp. 2016;(110). doi: 10.3791/53613.

Pichon A., Jeton F., El Hasnaoui-Saadani R., Hagström L., Launay T., Beaudry M., Marchant D., Quidu P., Macarlupu J.L., Favret F., Richalet J.P., Voituron N. (2016). Erythropoietin and the use of a transgenic model of erythropoietin-deficient mice. Hypoxia (Auckl) 4:29-39.

Uzunhan Y, Bernard O, Marchant D, Dard N, Vanneaux V, Larghero J, Gille T, Clerici C, Valeyre D, Nunes H, Boncoeur E, Planès C. Mesenchymal stem cells protect from hypoxia-induced alveolar epithelial-mesenchymal transition. Am J Physiol Lung Cell Mol Physiol. 2016;310(5):L439-51. [IF=4.28]

Woorons X, Mucci P, Richalet JP, Pichon A. Hypoventilation Training at Supramaximal Intensity Improves Swimming Performance. Med Sci Sports Exerc. 2016;48(6):1119-28. [IF=4.14]

Jeny F, Fargelat A, Laurent-Roussel S, Nault JC, Dupin N, Grange P, Nunes H, Valeyre D. Pulmonary Consolidations due to Secondary Syphilis with Positive Bronchial Washing Immunohistochemistry. Am J Respir Crit Care Med. 2016;193(9):1061-2. [IF=13.20]

Uzunhan Y, Ferrah L, Brillet PY, Dhote R, Valeyre D, Nunes H. Comment on: rituximab in autoimmune connective tissue disease-associated interstitial lung disease. Rheumatology (Oxford). 2016 Aug 21. pii: kew311.

Borie R, Tabèze L, Thabut G, Nunes H, Cottin V, Marchand-Adam S, Prevot G, Tazi A, Cadranel J, Mal H, Wemeau-Stervinou L, Bergeron Lafaurie A, Israel-Biet D, Picard C, Reynaud Gaubert M, Jouneau S, Naccache JM, Mankikian J, Ménard C, Cordier JF, Valeyre D, Reocreux M, Grandchamp B, Revy P, Kannengiesser C, Crestani B. Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis. Eur Respir J. 2016 Dec;48(6):1721-1731. [IF=10.57]

Bitoun S, Bouvry D, Borie R, Mahevas M, Sacre K, Haroche J, Psimaras D, Pottier C, Mathian A, Hie M, Boutin DL, Papo T, Godeau B, Valeyre D, Nunes H, Amoura Z, Cohen Aubart F. Treatment of neurosarcoidosis: A comparative study of methotrexate and mycophenolate mofetil. Neurology. 2016 Dec 13;87(24):2517-2521. Epub 2016 Nov 16. [IF=7.59]

Jacquelin V, Mekinian A, Brillet PY, Nunes H, Fain O, Valeyre D, Soussan M. FDG-PET/CT in the prediction of pulmonary function improvement in nonspecific interstitial pneumonia. A Pilot Study. Eur J Radiol. 2016 Dec;85(12):2200-2205. [IF=2.46]

Jamilloux Y, Maucort-Boulch D, Kerever S, Gerfaud-Valentin M, Broussolle C, Eb M, Valeyre D, Seve P. Sarcoidosis-related mortality in France: a multiple-cause-of-death analysis. Eur Respir J. 2016 Sep 22. pii: ERJ-00457-2016. [IF=10.57]

Kishore A, Žižková V, Kocourková L, Petrkova J, Bouros E, Nunes H, Loštáková V, Müller-Quernheim J, Zissel G, Kolek V, Bouros D, Valeyre D, Petrek M. Association Study for 26 Candidate Loci in Idiopathic Pulmonary Fibrosis Patients from Four European Populations. Front Immunol. 2016;7:274. [IF=6.42].

Challal S, Semerano L, Nunes H, Valeyre D, Boissier MC, Saidenberg-Kermanac'h N. Teriparatide for osteoporosis in patients with sarcoidosis: Report on risk-benefit ratio in four cases. Joint Bone Spine. 2016;83(3):344-5. [IF=3.33]

Ghrenassia E, Mekinian A, Chapelon-Albric C, Levy P, Cosnes J, Sève P, Lefèvre G, Dhote R, Launay D, Prendki V, Morell-Dubois S, Sadoun D, Mehdaoui A, Soussan M, Bourrier A, Ricard L, Benamouzig R, Valeyre D, Fain O; Groupe Sarcoïdose Francophone. Digestive-tract sarcoidosis: French nationwide case-control study of 25 cases. Medicine (Baltimore). 2016 Jul;95(29):e4279. [IF=5.72]

Lancaster L, Albera C, Bradford WZ, Costabel U, du Bois RM, Fagan EA, Fishman RS, Glaspole I, Glassberg MK, King TE Jr, Lederer DJ, Lin Z, Nathan SD, Pereira CA, Swigris JJ, Valeyre D, Noble PW. Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials. BMJ Open Respir Res. 2016;3(1):e000105.

Nathan SD, Albera C, Bradford WZ, Costabel U, du Bois RM, Fagan EA, Fishman RS, Glaspole I, Glassberg MK, Glasscock KF, King TE Jr, Lancaster L, Lederer DJ, Lin Z, Pereira CA, Swigris JJ, Valeyre D, Noble PW, Wells AU. Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis. Thorax. 2016;71(5):429-35. [IF=8.27]

Noble PW, Albera C, Bradford WZ, Costabel U, du Bois RM, Fagan EA, Fishman RS, Glaspole I, Glassberg MK, Lancaster L, Lederer DJ, Leff JA, Nathan SD, Pereira CA, Swigris JJ, Valeyre D, King TE Jr. Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials. Eur Respir J. 2016;47(1):243-53. [IF=10.57]

Obert J, Freynet O, Nunes H, Brillet PY, Miyara M, Dhote R, Valeyre D, Naccache JM. Outcome and prognostic factors in a French cohort of patients with myositis-associated interstitial lung disease. Rheumatol Int. 2016 Oct 8. [IF=1.82]

Tazi A, de Margerie-Mellon C, Vercellino L, Naccache JM, Fry S, Dominique S, Jouneau S, Lorillon G, Bugnet E, Chiron R, Wallaert B, Valeyre D, Chevret S. Extrathoracic investigation in adult patients with isolated pulmonary langerhans cell histiocytosis. Orphanet J Rare Dis. 2016;11:11. [IF=3.51]

Laouafa S, Elliot-Portal E, Revollo S, Schneider Gasser EM, Joseph V, Voituron N, Gassmann M, Soliz J. Hypercapnic ventilatory response is decreased in a mouse model of excessive erythrocytosis. Am J Physiol Regul Integr Comp Physiol. 2016 Sep 7:ajpregu.00226.2016. [IF=2.04]

Nathan N, Giraud V, Picard C, Nunes H, Dastot-Le Moal F, Copin B, Galeron L, De Ligniville A, Kuziner N, Reynaud-Gaubert M, Valeyre D, Couderc LJ, Chinet T, Borie R, Crestani B, Simansour M, Nau V, Tissier S, Duquesnoy P, Mansour-Hendili L, Legendre M, Kannengiesser C, Coulomb-L'Hermine A, Gouya L, Amselem S, Clement A. Germline SFTPA1 mutation in familial idiopathic interstitial pneumonia and lung cancer. Hum Mol Genet. 2016;25(8):1457-67. [IF=5.34]